Share of U.S. adults who felt MMR vaccine benefits outweigh risks 2016, by age

This survey shows the percentage of U.S. adults who felt the benefits of the measles, mumps and rubella (MMR) vaccine outweigh the risks as of June 2016, by age. It was found that while around 91 percent of those aged 30-49 years felt the benefits of the MMR vaccine outweighed the risks, only 79 percent of those aged 18 to 29 felt so.

Percentage of adults in the U.S. who thought the benefits of the measles, mumps and rubella vaccine outweighed the risks as of 2016, by age

Benefits outweigh the risksRisks outweigh the benefits
18 to 29 years79%18%
30 to 49 years91%9%
50 to 64 years91%6%
65 years and older90%6%
Total88%10%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2017

Region

United States

Survey time period

May 10 to June 6, 2016

Number of respondents

1,549 respondents

Age group

18 years and older

Method of interview

Online panel

Supplementary notes

MMR- Measles, mumps, rubella.
Note: Respondents who did not give an answer are not shown.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Health risk factors in the U.S."

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.